NCT05355701 2026-03-27A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.PfizerPhase 1 Recruiting267 enrolled
NCT05786924 2025-11-20Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive MalignanciesServierPhase 1/2 Recruiting554 enrolled